Capital expenditure · 2011–2025
Corcept Therapeutics capital expenditure
$211,000−90.3% · FY2025
Corcept Therapeutics (CORT) reported $211,000 in capital expenditure for fiscal 2025, −90.3% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $211,000 | −90.3% | Open → |
| FY20242024-12-31 | $2.2M | +1,462.6% | Open → |
| FY20232023-12-31 | $139,000 | −66.3% | Open → |
| FY20222022-12-31 | $413,000 | −11.9% | Open → |
| FY20212021-12-31 | $469,000 | −62.1% | Open → |
| FY20202020-12-31 | $1.2M | +13.8% | Open → |
| FY20192019-12-31 | $1.1M | +265.1% | Open → |
| FY20182018-12-31 | $298,000 | −28.9% | Open → |
| FY20172017-12-31 | $419,000 | +116.0% | Open → |
| FY20162016-12-31 | $194,000 | +1,041.2% | Open → |
| FY20152015-12-31 | $17,000 | −90.2% | Open → |
| FY20142014-12-31 | $174,000 | +37.0% | Open → |
| FY20132013-12-31 | $127,000 | −15.9% | Open → |
| FY20122012-12-31 | $151,000 | +504.0% | Open → |
| FY20112011-12-31 | $25,000 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +16.5%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Corcept Therapeutics capital expenditure |url=https://companiesranked.com/en/company/corcept-therapeutics/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Corcept Therapeutics capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/corcept-therapeutics/capital-expenditureBibTeX
@misc{companiesranked-en-company-corcept-therapeutics-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Corcept Therapeutics capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/corcept-therapeutics/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001628280-26-011091 · February 24, 2026
{{cite web |title=Corcept Therapeutics capital expenditure — 10-K (0001628280-26-011091) |url=https://www.sec.gov/Archives/edgar/data/1088856/000162828026011091/cort-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.